Grant: Doctoral Research Award: Canada Graduate Scholarships
Toronto Metropolitan University
$105,000.00
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
FY 2021-22
Summary
Cancer cells exhibit large differences in metabolism compared to healthy cells, particularly in how certain nutrients are used as fuel by cancer cells. Cancer cells not only have unique demands for specific nutrients, but are exposed to a unique environment within a tumor that provides limited access to many nutrients and oxygen. Through a poorly understood set of mechanism(s), cancer cells are able to adapt their metabolism to the nutrients in this otherwise restrictive environment, to not only survive, but thrive. Both healthy and cancer cells have a metabolic "fuel gauge" protein called AMPK that senses the availability of certain nutrients and then dictates the functions a cell is able to perform. How metabolic energy sensors such as AMPK are triggered to allow for this cancer cell nutrient and metabolism adaptation remains poorly understood, and understanding this is critical to reveal new weaknesses in cancer that can be used as targets for new therapies. In addition, cancer cell migration is a key component of cancer cell invasion and metastasis (cancer spreading). The process of cell migration is controlled by proteins known as integrins, and how metabolic sensors such as AMPK regulate integrin function is poorly understood. This research aims to understand how a novel set of signals triggered by AMPK may be a missing link in how cancer cells sense and adapt to otherwise restrictive nutrient conditions. Understanding how a cancer cell may uniquely use AMPK to adapt, thrive, and undergo metastasis may lead to the development of novel pharmacological drug targets for cancer therapy.
Department
Program
Doctoral Research Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
459043
Name
Orofiamma Laura A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Metabolic control of integrin membrane traffic by AMP-activated protein kinase controls cell migration.
Programtype2
Studentship Programs
Orgnameinp2
Toronto Metropolitan University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Breast Cancer; Cell Migration And Invasion; Membrane Traffic; Metabolic Stress; Metabolism; Total Internal Reflection Fluorescence Microscopy
Abstract
Cancer cells exhibit large differences in metabolism compared to healthy cells, particularly in how certain nutrients are used as fuel by cancer cells. Cancer cells not only have unique demands for specific nutrients, but are exposed to a unique environment within a tumor that provides limited access to many nutrients and oxygen. Through a poorly understood set of mechanism(s), cancer cells are able to adapt their metabolism to the nutrients in this otherwise restrictive environment, to not only survive, but thrive. Both healthy and cancer cells have a metabolic "fuel gauge" protein called AMPK that senses the availability of certain nutrients and then dictates the functions a cell is able to perform. How metabolic energy sensors such as AMPK are triggered to allow for this cancer cell nutrient and metabolism adaptation remains poorly understood, and understanding this is critical to reveal new weaknesses in cancer that can be used as targets for new therapies. In addition, cancer cell migration is a key component of cancer cell invasion and metastasis (cancer spreading). The process of cell migration is controlled by proteins known as integrins, and how metabolic sensors such as AMPK regulate integrin function is poorly understood. This research aims to understand how a novel set of signals triggered by AMPK may be a missing link in how cancer cells sense and adapt to otherwise restrictive nutrient conditions. Understanding how a cancer cell may uniquely use AMPK to adapt, thrive, and undergo metastasis may lead to the development of novel pharmacological drug targets for cancer therapy.
Competitiondate
202111
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Orofiamma, Laura A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~